Biopsy of the sentinel lymph nodes using indocyanine green fluorescence method in local cutaneous melanoma

Cover Page

Cite item

Full Text

Abstract

Timely diagnosis and treatment of cutaneous melanoma are important problems as mortality for this pathology exceeds 70 % of all skin tumors, and in Russia this disease is diagnosed at stage I only in 35.7 % of cases. Correctly selected therapy offers good results, but effective treatment requires accurate staging involving detection of metastases in the sentinel lymph nodes which cannot be identified clinically. This review analyzes study data showing the effectiveness of detection of the sentinel lymph nodes using indocyanine green fluorescence method.

About the authors

K. S. Titov

S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department; Peoples’ Friendship University of Russia

ORCID iD: 0000-0003-4460-9136

5 2nd Botkinskij proezd, Moscow 125284

6 Miklukho-Maklaya St., Moscow 117198

Russian Federation

Sh. R. Dzhamilov

S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department

Author for correspondence.
Email: 9211824533@mail.ru
ORCID iD: 0000-0002-1445-7277

5 2nd Botkinskij proezd, Moscow 125284

Russian Federation

I. N. Lebedinsky

S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department

ORCID iD: 0000-0001-7735-1106

5 2nd Botkinskij proezd, Moscow 125284

Russian Federation

A. S. Sukhotko

S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department

ORCID iD: 0000-0002-2337-5919

5 2nd Botkinskij proezd, Moscow 125284

Russian Federation

A. I. Evsikov

S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department

ORCID iD: 0000-0003-0502-5517

5 2nd Botkinskij proezd, Moscow 125284

Russian Federation

M. V. Sorokina

S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department

ORCID iD: 0000-0002-4436-8101

5 2nd Botkinskij proezd, Moscow 125284

Russian Federation

G. M. Zapirov

Peoples’ Friendship University of Russia; P.A. Herzen Moscow Research Oncological Institute – branch of the National Medical Research Center of Radiology, Ministry of Health of Russia

ORCID iD: 0000-0001-7154-3326

6 Miklukho-Maklaya St., Moscow 117198

3 2nd Botkinskij proezd, Moscow 125284

Russian Federation

D. N. Grekov

S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department; Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

ORCID iD: 0000-0001-8391-1210

5 2nd Botkinskij proezd, Moscow 125284

Bld. 1, 2/1 Barricadnaya St., Moscow 125993

Russian Federation

References

  1. Malignant neoplasms in Russia in 2013 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, G.V. Petrova. Moscow: P.A. Herzen Moscow State Medical Research Institute – branch of the Federal State Budgetary Institution “P.A. Herzen NMIRC” of the Ministry of Health of Russia, 2015. (In Russ.).
  2. Malignant neoplasms in Russia in 2015 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, G. V. Petrova. Moscow: P.A. Herzen Moscow State Medical Research Institute – branch of the Federal State Budgetary Institution “P.A. Herzen NMIRC” of the Ministry of Health of Russia, 2017. (In Russ.).
  3. Malignant neoplasms in Russia in 2017 (morbidity and mortality). Moscow: P.A. Herzen Moscow State Medical Research Institute – branch of the Federal State Budgetary Institution “P.A. Herzen NMIRC” of the Ministry of Health of Russia, 2018. (In Russ.).
  4. Malignant neoplasms in Russia in 2020 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, G.V. Petrova. Moscow: P.A. Herzen Moscow State Medical Research Institute – branch of the Federal State Budgetary Institution “P.A. Herzen NMIRC” of the Ministry of Health of Russia, 2021. 252 p. (In Russ.).
  5. Petrova G.V., Kaprin A.D., Gretsova O.P., Starinsky V.V. Malignant neoplasms in Russia. Review of statistical information for 1993–2013. General ed. by A.D. Kaprin, V.V. Starinsky. Moscow, 2015. Pp. 306–339. (In Russ.).
  6. The state of oncological care to the population of Russia in 2015. Ed. by A.D. Kaprin, V.V. Starinsky, G.V. Petrova. Moscow: P.A. Herzen Moscow State Medical Research Institute – branch of the Federal State Budgetary Institution “P.A. Herzen NMIRC” of the Ministry of Health of Russia, 2016. 236 p. (In Russ.).
  7. The state of oncological care to the population of Russia in 2016. Ed. by A.D. Kaprin, V.V. Starinsky, G.V. Petrova. Moscow: P.A. Herzen Moscow State Medical Research Institute – branch of the Federal State Budgetary Institution “P.A. Herzen NMIRC” of the Ministry of Health of Russia, 2017. 236 p. (In Russ.).
  8. Practical recommendations for the treatment of melanoma of the skin RUSSCO, 2021. (In Russ.). Available at: https://rosoncoweb.ru/
  9. Valsecchi M.E., Silbermins D., de Rosa N. et al. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis. J Clin Oncol 2011;29(11):1479–87. doi: 10.1200/JCO.2010.33.1884
  10. Morton D.L., Thompson J.F., Cochran A.J. et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 2014;370(7):599–609. doi: 10.1056/NEJMoa1310460
  11. Chang J.M., Kosiorek H.E., Dueck A.C. et al. Stratifying SLN incidence in intermediate thickness melanoma patients. Am J Surg 2018;215(4):699–706. doi: 10.1016/j.amjsurg.2017.12.009
  12. Kogure K., David N.J., Yamanouchi U., Choromokos E. Infrared absorption angiography of the fundus circulation. Arch Ophthalmol 1970;83(2):209-14. doi: 10.1001/archopht.1970.00990030211015
  13. Marshall M.V., Rasmussen J.C., Tan I.C. et al. Near-infrared fluorescence imaging in humans with indocyanine green: a review and update. Open Surg Oncol J 2010;2(2):12–25. doi: 10.2174/1876504101002010012
  14. Vahabzadeh-Hagh A.M., Blackwell K.E., Abemayor E., St. John M.A. Sentinel lymph node biopsy in cutaneous melanoma of the head and neck using the indocyanine green SPY Elite system. Am J Otolaryngol 2018;39(5):485–8. doi: 10.1016/j.amjoto.2018.05.006
  15. Shao J. , Fan Jiang F., Murong Hu M. et al. The role of FOS-mediated autophagy activation in the indocyanine green-based photodynamic therapy for treating melanoma. J Photochem Photobiol 2020;214:112101. doi: 10.1016/j.jphotobiol.2020.112101
  16. Lese I., Constantinescu M.A., Leckenby J.I. et al. Transcutaneous sentinel lymph node detection in cutaneous melanoma with indocyanine green and near-infrared fluorescence: a diagnostic sensitivity study. Medicine 2022;101(36):e30424. doi: 10.1097/MD.0000000000030424
  17. Knackstedt R., Couto R.A., Ko J. et al. Indocyanine green fluorescence imaging with lymphoscintigraphy for sentinel node biopsy in melanoma: increasing the sentinel lymph node-positive rate. Ann Surg Oncol 2019;26(11):3550–60. doi: 10.1245/s10434-019-07617-z
  18. Knackstedt R., Couto R.A., Gastman B. Indocyanine green fluorescence imaging with lymphoscintigraphy for sentinel node biopsy in head and neck melanoma. Clinics (Sao Paulo) 2018;228:77–83. doi: 10.1016/j.jss.2018.02.064
  19. Namikawa K., Tsutsumida A., Tanaka R. et al. Limitation of indocyanine green fluorescence in identifying sentinel lymph node prior to skin incision in cutaneous melanoma. Int J Clin Oncol 2014;19(1):198–203. doi: 10.1007/s10147-013-0524-y
  20. Chang J.W., Huang Y.-L., Chang Y.-Y. et al. Sentinel lymph node biopsy was associated with favorable survival outcomes for patients with clinically node-negative asian melanoma. Cancer Manag Res 2019;119: 655–64. doi: 10.2147/CMAR.S227837
  21. Bae Y.C., Jeong D.K., Kim K.H. et al. Adequacy of sentinel lymph node biopsy in malignant melanoma of the trunk and extremities: clinical observations regarding prognosis. Arch Plast Surg 2020;47(1):42–8. doi: 10.5999/aps.2019.00934
  22. Pameijer C.R., Rogerio A.L., Neves I., Zhu J. Indocyanine green and fluorescence lymphangiography for sentinel node identification in patients with melanoma. Am J Surg 2018;216(3):558–61. doi: 10.1016/j.amjsurg.2018.01.009
  23. Korn J.M., Tellez-Diaz A., Bartz-Kurycki M., Gastman B. Indocyanine green SPY elite-assisted sentinel lymph node biopsy in cutaneous melanoma. Plast Reconstr Surg 2014;133(4):914–22. doi: 10.1097/PRS.0000000000000006
  24. Namikawa K., Tsutsumida A., Tanaka R. et al. Limitation of indocyanine green fluorescence in identifying sentinel lymph node prior to skin incision in cutaneous melanoma. Int J Clin Oncol 2014;19(1):198–203. doi: 10.1007/s10147-013-0524-y
  25. Van den Berg N.S., Brouwer O.R., Schaafsma B.E. et al. Multimodal surgical guidance during sentinel node biopsy for melanoma: combined gamma tracing and fluorescence imaging of the sentinel node through use of the hybrid tracer indocyanine green-(99m)Tc-nanocolloid. Radiology 2015;275(2):521–9. doi: 10.1148/radiol.14140322
  26. Brouwer O.R., Klop W.M., Buckle T. et al. Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer. Ann Surg Oncol 2012;19(6):1988–94. doi: 10.1245/s10434-011-2180-7
  27. Vahabzadeh-Hagh A.M., Blackwell K.E., Abemayor E., St John M.A. Sentinel lymph node biopsy in cutaneous melanoma of the head and neck using the indocyanine green SPY Elite system. Am J Otolaryngol 2018;39(5):485–8. doi: 10.1016/j.amjoto.2018.05.006
  28. Gilmore D.M., Khullar O.V., Gioux S. et al. Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma. Ann Surg Oncol 2013;20(7):2357–63. doi: 10.1245/s10434-013-2905-x
  29. Van der Vorst J.R., Schaafsma B.E., Verbeek F.P. et al. Dose optimization for nearinfrared fluorescence sentinel lymph node mapping in patients with melanoma. Br J Dermatol 2013;168(1):93–8. doi: 10.1111/bjd.12059
  30. Cloyd J.M., Wapnir I.L., Read B.M. et al. Indocyanine green and fluorescence lymphangiography for sentinel lymph node identification in cutaneous melanoma. J Surg Oncol 2014;110(7):888–92. doi: 10.1002/jso.23745
  31. Knackstedt R.W., Couto R.A., Gastman B. Indocyanine green fluorescence imaging with lymphoscintigraphy for sentinel node biopsy in head and neck melanoma. J Surg Res 2018;228:77–83. DOI: 10.1016 /j.jss.2018.02.064
  32. Knackstedt R., Couto R.A., Ko J. et al. Indocyanine green fluorescence imaging with lymphoscintigraphy for sentinel node biopsy in melanoma: increasing the sentinel lymph node-positive rate. Ann Surg Oncol 2019; 26(11):3550–60. doi: 10.1245/s10434-019-07617-z
  33. Goppner D., Nekwasil S., Jellestad A. et al. Indocyanine green-assisted sentinel lymph node biopsy in melanoma using the “FOVIS” system. J Dtsch Dermatol Ges 2017;15(2):169–78. doi: 10.1111/ddg.12794
  34. Stoffels I., Dissemond J., Poppel T. et al. Intraoperative fluorescence imaging for sentinel lymph node detection: prospective clinical trial to compare the usefulness of indocyanine green vs technetium Tc 99m for identification of sentinel lymph nodes. JAMA Surg 2015;150(7):617–23. doi: 10.1001/jamasurg.2014.3502
  35. Pameijer C.R., Leung A., Neves R.I., Zhu J. Indocyanine green and fluorescence lymphangiography for sentinel node identification in patients with melanoma. Am J Surg 2018;216(3):558–61. doi: 10.1016/j.amjsurg.2018.01.009
  36. Somashekhar S.P., Kumar C.R., Ashwin K.R. et al. Can low cost indo cyanine green florescence technique for sentinel lymph node biopsy replace dual dye (radio-colloid & blue dye) technique in early breast cancer: a prospective two arm comparative study. Clin Breast Cancer 2020;2095:e576–83. doi: 10.1016/j.clbc.2020.03.013

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2023 Titov K.S., Dzhamilov S.R., Lebedinsky I.N., Sukhotko A.S., Evsikov A.I., Sorokina M.V., Zapirov G.M., Grekov D.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-66671 от  09.11.2009.